Lessons from randomised controlled trials of continuous positive airways pressure therapy in the prevention of cardiovascular morbidity and mortality

Obstructive sleep apnoea (OSA) has an established independent relationship with cardiovascular disease, with a multitude of clinical cohort and longitudinal population studies showing a significantly increased risk of cardiovascular morbidity and mortality in subjects with severe OSA (1-3).